Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Theriva™ Biologics VIRAGE Phase 2b Pancreatic Cancer Clinical Trial of VCN-01 Top line Data Update

    Details to follow.
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Praxis Precision Medicines virtual investor event to discuss clinical programs in Developmental and Epileptic Encephalopathies (DEEs)

    Join Praxis Precision Medicines for a virtual investor event hosted by company management, who will focus on their DEE clinical…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    • Foghorn Therapeutics Virtual Investor Event to Review Key Pipelines Updates in Conjunction with 2025 AACR Meeting

    Join Foghorn Therapeutics for a virtual investor event to review updates for FHD-909, a potential first-in-class selective SMARCA2 inhibitor, including…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Relmada Therapeutics Virtual KOL Event to Discuss Topline Phase 2 Data for NDV-01 for High-Grade Non-Muscle Invasive Bladder Cancer (HG-NMIBC) at AUA 2025

    Join Relmada Therapeutics for a virtual key opinion leader (KOL) event featuring Boris Chertin, MD (Department of Urology, Shaare Zedek…
    TIME: 4:30 PM EDT
    LOCATION: Virtual
    View Details

    Leap Therapeutics Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC)

    Join Leap Therapeutics for a virtual key opinion leader (KOL) event featuring Zev A. Wainberg, MD (Professor of Medicine at UCLA…
    TIME: 2:30 PM EDT
    LOCATION: Virtual
    View Details

    M6P Therapeutics: The Lysosomal Storage Disorders treatment landscape with a focus on Pompe Disease and M6P’s S1S3 co-expression platform technology

    Join M6P Therapeutics for a virtual key opinion leader (KOL) event featuring Professor Gregory Enns (Stanford Medicine), who will provide…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    Oculis In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

    Join Oculis for an in-person and virtual R&D Day to provide an update on Oculis’ portfolio of innovative late-stage clinical…
    TIME: 10:00 AM EDT
    LOCATION: InterContinental New York Barclay, 111 E 48th St, New York, NY 10017
    View Details

    Apnimed Dawn of a New Era for Obstructive Sleep Apnea: How Pharmacotherapy Will Change the Treatment Paradigm

    Join Apnimed for a virtual investor event featuring key opinion leaders (KOLs) Douglas Kirsch, MD, FAAN, FAASM (Wake Forest University),…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    BioVie KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and BioVie’s ADDRESS-LC Trial

    Join BioVie Inc. for a virtual investor event featuring key opinion leader (KOL) Lindsay McAlpine, MD, BSc (Yale University), who will…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    NervGen Pharma Virtual Investor Event to Discuss the Current Spinal Cord Injury Treatment Landscape and NervGen’s Phase 1b/2a Trial Evaluating NVG-291 in Spinal Cord Injury

    Join NervGen Pharma Corp. for a virtual investor event featuring key opinion leaders (KOL) Monica Perez, PT, PhD (Northwestern University) and Steven Kirshblum,…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    BiomX Virtual KOL Event to Discuss Topline Results from the Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

    Join BiomX for a virtual key opinion leader (KOL) event featuring Dr. Robert T. “Chip” Schooley, MD (University of California, San…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    • Traws Pharma Investor Event to discuss Bird Flu and COVID, the need for new antiviral drugs and the differentiated features of Traws Pharma’s oral small molecule product candidates

    Join Traws Pharma (Traws) for an investor event featuring Robert R. Redfield, MD, former Director of the U.S. Centers for Disease…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Actinium Pharmaceuticals Virtual Investor Event to Discuss Revitalized Clinical Programs, Expanded Market Opportunities for Actimab-A and Iomab-ACT and New Actimab-A Solid Tumor Program with Outlook for 2025 Milestones

    Join Actinium Pharmaceuticals for a virtual investor event featuring key opinion leader (KOL) Ehab Atallah, MD (Medical College of Wisconsin), who…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Aura Biosciences Virtual Urologic Oncology Investor Event to Discuss Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer (NMIBC)

    Join Aura Biosciences for a virtual urologic oncology investor event featuring key opinion leaders (KOLs) Neal Shore, MD, FACS (Carolina Urologic…
    TIME: 4:30 PM EDT
    LOCATION: Virtual
    View Details

    Santhera Pharmaceuticals Capital Markets Day to Discuss the Duchenne Muscular Dystrophy Treatment Landscape and Santhera’s Commercial Strategy

    Join Santhera for its virtual Capital Markets Day where Dario Eklund, CEO, Shabir Hasham, CMO, and Catherine Isted, CFO, will…
    TIME: 9:00 AM EDT
    LOCATION: Virtual
    View Details

    UNITY Biotechnology Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME)

    Join UNITY Biotechnology for a virtual investor event featuring prominent ophthalmology key opinion leader (KOL) Robert Bhisitkul, MD, PhD from…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details